OmniAb (OABI) Other Working Capital Changes (2022 - 2026)
OmniAb's (OABI) quarterly Other Working Capital Changes came in at -$748000.0 in Q1 2026, down 9.2% year-on-year from -$823762.1 in Q1 2025, and up 58.88% on a QoQ basis from -$1.8 million in Q4 2025.
OmniAb (OABI) Other Working Capital Changes (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Other Working Capital Changes data on file, last reported at -$748000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 9.2% year-over-year to -$748000.0 in Q1 2026; TTM through Mar 2026 was -$2.9 million, a 52.15% increase from a year earlier, with the FY2025 full-year figure at -$2.8 million, up 52.74% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$748000.0, up from -$1.8 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for OABI reached as high as $3.9 million in Q4 2022 and fell as low as -$1.4 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged $138117.6 across 5 years, with a median of -$52000.0 in 2022.
- Across the five-year window, Other Working Capital Changes surged 211.82% in 2023 and slumped 222.87% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$3.1 million in 2022, then jumped by 211.82% to $3.5 million in 2023, then slumped by 222.87% to -$4.3 million in 2024, then jumped by 57.36% to -$1.8 million in 2025, then soared by 58.88% to -$748000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$748000.0 in Q1 2026, -$1.8 million in Q4 2025, and $370000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Sep 30, 2025 | 457,000.00 |
| Sep 30, 2025 | 457,000.00 |
| Sep 30, 2025 | 457,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -301,000.00 |
| Dec 31, 2024 | -301,000.00 |
| Dec 31, 2024 | -301,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Sep 30, 2024 | 534,000.00 |